JP Morgan Chase’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $630M | Buy |
2,668,749
+352,105
| +15% | +$73.2M | 0.03% | 395 |
|
|
2026
Q1 | $478M | Sell |
2,316,644
-314,159
| -12% | -$67.7M | 0.03% | 419 |
|
|
2025
Q4 | $541M | Sell |
2,630,803
-267,935
| -9% | -$50.4M | 0.03% | 381 |
|
|
2025
Q3 | $455M | Buy |
2,898,738
+376,353
| +15% | +$58.1M | 0.03% | 436 |
|
|
2025
Q2 | $424M | Sell |
2,522,385
-1,653,607
| -40% | -$245M | 0.03% | 453 |
|
|
2025
Q1 | $575M | Buy |
4,175,992
+1,193,983
| +40% | +$152M | 0.04% | 356 |
|
|
2024
Q4 | $353M | Buy |
2,982,009
+32,852
| +1% | +$3.84M | 0.03% | 475 |
|
|
2024
Q3 | $326M | Sell |
2,949,157
-103,734
| -3% | -$10.8M | 0.02% | 510 |
|
|
2024
Q2 | $300M | Buy |
3,052,891
+711,951
| +30% | +$72.5M | 0.02% | 502 |
|
|
2024
Q1 | $262M | Buy |
2,340,940
+1,134,364
| +94% | +$122M | 0.02% | 566 |
|
|
2023
Q4 | $122M | Buy |
1,206,576
+23,219
| +2% | +$2.3M | 0.01% | 798 |
|
|
2023
Q3 | $103M | Sell |
1,183,357
-273,185
| -19% | -$24.7M | 0.01% | 807 |
|
|
2023
Q2 | $138M | Buy |
1,456,542
+394,224
| +37% | +$33.3M | 0.02% | 690 |
|
|
2023
Q1 | $80.2M | Sell |
1,062,318
-348,090
| -25% | -$26.3M | 0.01% | 883 |
|
|
2022
Q4 | $108M | Sell |
1,410,408
-924,141
| -40% | -$70.2M | 0.01% | 741 |
|
|
2022
Q3 | $156M | Buy |
2,334,549
+52,863
| +2% | +$3.35M | 0.02% | 567 |
|
|
2022
Q2 | $119M | Buy |
2,281,686
+18,406
| +0.8% | +$1.05M | 0.02% | 682 |
|
|
2022
Q1 | $128M | Buy |
2,263,280
+1,034,840
| +84% | +$55.4M | 0.02% | 733 |
|
|
2021
Q4 | $63.3M | Sell |
1,228,440
-1,000,891
| -45% | -$49.1M | 0.01% | 1087 |
|
|
2021
Q3 | $110M | Buy |
2,229,331
+852,955
| +62% | +$46.3M | 0.01% | 817 |
|
|
2021
Q2 | $78.6M | Sell |
1,376,376
-107,089
| -7% | -$6.26M | 0.01% | 1001 |
|
|
2021
Q1 | $90.1M | Buy |
1,483,465
+530,194
| +56% | +$29.3M | 0.01% | 896 |
|
|
2020
Q4 | $51.1M | Buy |
953,271
+283,129
| +42% | +$14.7M | 0.01% | 1059 |
|
|
2020
Q3 | $31.4M | Sell |
670,142
-211,441
| -24% | -$10.8M | 0.01% | 1213 |
|
|
2020
Q2 | $46M | Buy |
881,583
+268,364
| +44% | +$13.8M | 0.01% | 925 |
|
|
2020
Q1 | $29.4M | Buy |
613,219
+134,332
| +28% | +$6.97M | 0.01% | 1044 |
|
|
2019
Q4 | $24.2M | Sell |
478,887
-1,813,978
| -79% | -$93.7M | ﹤0.01% | 1431 |
|
|
2019
Q3 | $108M | Buy |
2,292,865
+1,294,459
| +130% | +$59.1M | 0.02% | 647 |
|
|
2019
Q2 | $46.5M | Sell |
998,406
-36,244
| -4% | -$1.67M | 0.01% | 1009 |
|
|
2019
Q1 | $49.8M | Sell |
1,034,650
-175,405
| -14% | -$8.79M | 0.01% | 953 |
|
|
2018
Q4 | $54M | Buy |
1,210,055
+592,744
| +96% | +$30.9M | 0.01% | 869 |
|
|
2018
Q3 | $33.3M | Sell |
617,311
-513,710
| -45% | -$26.3M | 0.01% | 1276 |
|
|
2018
Q2 | $55.2M | Buy |
1,131,021
+192,188
| +20% | +$10.9M | 0.01% | 913 |
|
|
2018
Q1 | $58.8M | Sell |
938,833
-550,009
| -37% | -$37.7M | 0.01% | 850 |
|
|
2017
Q4 | $91.2M | Sell |
1,488,842
-95,541
| -6% | -$5.91M | 0.02% | 702 |
|
|
2017
Q3 | $106M | Buy |
1,584,383
+481,046
| +44% | +$34M | 0.02% | 605 |
|
|
2017
Q2 | $86M | Buy |
1,103,337
+479,072
| +77% | +$36.2M | 0.02% | 672 |
|
|
2017
Q1 | $50.9M | Buy |
624,265
+145,498
| +30% | +$11.5M | 0.01% | 936 |
|
|
2016
Q4 | $34.5M | Buy |
478,767
+90,615
| +23% | +$6.55M | 0.01% | 1122 |
|
|
2016
Q3 | $30.2M | Sell |
388,152
-876,369
| -69% | -$70.8M | 0.01% | 1110 |
|
|
2016
Q2 | $98.6M | Sell |
1,264,521
-553,497
| -30% | -$44.1M | 0.02% | 569 |
|
|
2016
Q1 | $149M | Buy |
1,818,018
+15,770
| +0.9% | +$1.28M | 0.04% | 449 |
|
|
2015
Q4 | $161M | Buy |
1,802,248
+604,513
| +50% | +$51.3M | 0.04% | 437 |
|
|
2015
Q3 | $92M | Sell |
1,197,735
-1,047,775
| -47% | -$87.6M | 0.02% | 568 |
|
|
2015
Q2 | $188M | Buy |
2,245,510
+274,387
| +14% | +$24.2M | 0.04% | 411 |
|
|
2015
Q1 | $178M | Buy |
1,971,123
+446,828
| +29% | +$38.5M | 0.04% | 455 |
|
|
2014
Q4 | $123M | Buy |
1,524,295
+337,053
| +28% | +$26.6M | 0.03% | 561 |
|
|
2014
Q3 | $88.9M | Buy |
1,187,242
+159,143
| +15% | +$11.6M | 0.02% | 662 |
|
|
2014
Q2 | $70.5M | Buy |
1,028,099
+329,621
| +47% | +$22.4M | 0.02% | 689 |
|
|
2014
Q1 | $48.9M | Sell |
698,478
-78,261
| -10% | -$5.44M | 0.01% | 825 |
|
|
2013
Q4 | $51.9M | Sell |
776,739
-3,573,423
| -82% | -$218M | 0.01% | 789 |
|
|
2013
Q3 | $227M | Sell |
4,350,162
-2,130,720
| -33% | -$108M | 0.07% | 299 |
|
|
2013
Q2 | $306M | Buy |
+6,480,882
| New | +$296M | 0.1% | 246 |
|
Other funds holding CAH
JP Morgan Chase's CAH Position: Q2 2026 in Review
JP Morgan Chase increased its Cardinal Health (CAH) stake by 15% in Q2 2026, buying an estimated $73.2M and bringing the position to 2,668,749 shares worth $630M. The position accounts for 0.03% of the portfolio, ranked #395.
JP Morgan Chase first reported a position in CAH in Q2 2013 and has held it in 53 quarters since. 1,494 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- JP Morgan Chase held 2,668,749 shares of Cardinal Health worth $630M as of Q2 2026.
- JP Morgan Chase bought 352,105 Cardinal Health shares in Q2 2026, an estimated $73.2M.
- Cardinal Health made up 0.03% of JP Morgan Chase's portfolio in Q2 2026, its #395 holding.
- JP Morgan Chase first reported a position in Cardinal Health in Q2 2013 and has held it in 53 quarters since.
- 1,494 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.